Evaluating Statin Knowledge-Perceptions and Receptivity Following a Comprehensive Lifestyle Modification Program.

Alaina Pupulin, Jillian Ball, Ravi Bajaj, David A Alter

Abstract read

In one paragraph

Article in American journal of lifestyle medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.Patient preference and adherence · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alaina PupulinFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada (AP); Faculty of Art and Science, University of Toronto, Toronto, ON, Canada (JB); Faculty of Medicine, University of Toronto, Toronto, ON, Canada (RB, DAA); Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada (DAA); Rehabilitation Institute-University Health Network, University of Toronto, Toronto, ON, Canada (DAA); Institute for Clinical Evaluative Sciences, Toronto, ON, Canada (DAA).

Jillian BallFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada (AP); Faculty of Art and Science, University of Toronto, Toronto, ON, Canada (JB); Faculty of Medicine, University of Toronto, Toronto, ON, Canada (RB, DAA); Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada (DAA); Rehabilitation Institute-University Health Network, University of Toronto, Toronto, ON, Canada (DAA); Institute for Clinical Evaluative Sciences, Toronto, ON, Canada (DAA).

Ravi BajajFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada (AP); Faculty of Art and Science, University of Toronto, Toronto, ON, Canada (JB); Faculty of Medicine, University of Toronto, Toronto, ON, Canada (RB, DAA); Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada (DAA); Rehabilitation Institute-University Health Network, University of Toronto, Toronto, ON, Canada (DAA); Institute for Clinical Evaluative Sciences, Toronto, ON, Canada (DAA).

David A AlterFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada (AP); Faculty of Art and Science, University of Toronto, Toronto, ON, Canada (JB); Faculty of Medicine, University of Toronto, Toronto, ON, Canada (RB, DAA); Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada (DAA); Rehabilitation Institute-University Health Network, University of Toronto, Toronto, ON, Canada (DAA); Institute for Clinical Evaluative Sciences, Toronto, ON, Canada (DAA).ORCID https://orcid.org/0000-0002-5722-0202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Though clinical guidelines for cholesterol-lowering therapies advocate for both a trial of lifestyle modification and the initiation of statin medication when appropriate, the extent to which lifestyle modification may alter a patient's knowledge-perceptions and receptivity towards statins remains unclear. Methods: Following completion of a 6-month comprehensive lifestyle modification program, perceived changes in knowledge and receptivity towards statins were examined across prespecified subgroups of age, sex, and statin eligibility using a mixed-methods questionnaire. Quantitative and qualitative analyses incorporated binomial tests, McNemar's test, and thematic analyses. Results: Among 192 patients who completed the program and exit questionnaire between December 15, 2020 and July 2, 2021, 88.4% of patients indicated a perceived improvement in cholesterol and/or statin knowledge (P < . Conclusions: Patients' perceived knowledge and receptivity towards statins may improve following participation in a comprehensive therapeutic lifestyle modification program. Future research must evaluate the impact of these programs on statin uptake, compliance and outcomes.

Indexed as

lifestyle modificationmedication perspectivesstatin knowledge-perceptionsstatin receptivity

Identifiers

PMID41640983

DOI10.1177/15598276231163129

PMCPMC12864696

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.